AliveCor Expands AI Cardiac ECG Technology in Vietnam
MOUNTAIN VIEW, Calif., April 07, 2026 AliveCor Inc., a global leader in AI-powered cardiology solutions, has announced the regulatory...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MOUNTAIN VIEW, Calif., April 07, 2026 AliveCor Inc., a global leader in AI-powered cardiology solutions, has announced the regulatory...
NEEDHAM, Mass., April 3, 2026 Trialt, a global clinical research organization (CRO), has announced a strategic collaboration with Viedoc,...
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced a strategic collaboration with TriNetX to...
AMSTERDAM, Netherlands, March 26, 2026 Royal Philips announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
SECAUCUS, N.J., March 2, 2026 Quest Diagnostics (NYSE: DGX) has introduced Quest AI Companion, an AI-powered chat feature integrated...
WHITE PLAINS, NEW YORK, UNITED STATES — February 16, 2026 Retia Medical has received U.S. FDA 510(k) clearance for...
Houston, Texas | January 2026 — HeartX, a leading cardiovascular innovation accelerator, has officially opened applications for its 2026...
Seoul, South Korea — February 6, 2026 Neurophet has announced that the U.S. Food and Drug Administration (FDA) has...
BELLEVUE, Wash., January 27, 2026 — OSR Holdings, Inc. (NASDAQ: OSRH) has completed the acquisition of Woori IO Co.,...
SAN JOSE, Calif., January 20, 2026 — BrightInsight announced a $13 million strategic investment to accelerate development of its...
